Unanimously, however, work from many labs over the years has shown that depletion of NTC and PRP19-associated complexes is clearly detrimental to cancer cell resistance to genotoxic stress, and thus PRP19 inhibition could potentially improve the efficacy of treatment regimens by enhancing cell death and/or senescence. This evidence concerns the gene PRPF19 and cancer.